A2 Milk share price up after UBS reveals 5% stake in the company

UBS stands by its research as it's revealed that the Swiss bank has taken a massive 5% stake in the Australian infant formula company.

This morning a2 Milk Co Ltd revealed that Swiss banking giant UBS has built a 5% stake in the company.

When the markets opened in Australia, a2 Milk's share price was up 1.16%.

As we previously reported, UBS just recently upgraded their rating of a2 Milk to ‘buy’ from ‘neutral’ and slapped an increased 12-month price target of A$16.70 on the infant formula company.

UBS’s research report highlighted how a2 Milk’s unique product offerings, premium brand presence and the potential to expand its Chinese market share are all potential drivers of growth for the company.

UBS puts its money where its mouth is

It’s refreshing to see UBS Group AG stand behind its research, with the banking giant having bought some 36 million ordinary shares in a2 Milk over the last five months.

All up, this amounts to a 5.01% stake in a2 Milk.

The bank has been building its sizable position in the Australian company for some time now, with UBS’s London branch accumulating a2 Milk stock all the way back in March 2019.

Though not necessarily the price that UBS got in at, back in March 18, shares of a2 Milk Co Ltd traded for just A$13.44 per share.

By comparison, in the last month alone a2 Milk’s share price has risen 22.1% and currently trades at A$16.42 per share.

Analysts still mixed on a2 Milk

While UBS is evidently optimistic concerning a2 Milk’s prospects, other analysts seem less enthused.

According to the Wall Street Journal, of the 13 analysts covering the company: six rate it as a buy, four a hold and three a sell.

Ultimately, given that China remains a key part of a2 Milk’s growth strategy, potential head-winds from the US-China trade war may still be weighing on the minds of investors and analysts.

Even still, the company looks to be in a good financial position, having posted strong growth year-over-year in the first-half of 2019. In this period the company saw both revenue and earnings per share (EPS) increase 41% and 53%, respectively.

Year-to-date, a2 Milk (ASX: A2M) has far outpaced the ASX200, rising 57% since January.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

Please see important Research Disclaimer.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices
liveprices.javascriptrequired
liveprices.javascriptrequired

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

liveprices.javascriptrequired

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Monday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.